Knight Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025

Published: 2025-05-08 07:33:00 ET GUD.TO

Published on 05/08/2025 at 07:33, updated on 05/08/2025 at 10:38

Knight Therapeutics Inc. reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported sales was CAD 88.08 million compared to CAD 86.6 million a year ago. Net income was CAD 2.19 million compared to net loss of CAD 4.55 million a year ago.

Basic earnings per share from continuing operations was CAD 0.02 compared to basic loss per share from continuing operations of CAD 0.04 a year ago. Diluted earnings per share from continuing operations was CAD 0.02 compared to diluted loss per share from continuing operations of CAD 0.04 a year ago.